ArticleBlood advances2018

Safety and efficacy of combined ruxolitinib and decitabine in accelerated and blast-phase myeloproliferative neoplasms.

Raajit K Rampal et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.